DCGD Stock UPDATES Discovery Gold Corp (DCGD) 0.0035 09/13/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Discovery Gold Corp (DCGD) 0.0035 $DCGD

Discovery Gold Secures Extension of Edum Banso Concession Option Agreement in Ghana
ACCESSWIRE - Mon Aug 05, 6:40AM CDT
DENVER, CO, August 5, 2013 -(eTeligis via ACCESSWIRE)- Discovery Gold Corporation (OTCQB: DCGD) (the "Company" , a U.S. based mineral exploration company, is pleased to announce that its Ghana subsidiary, Discovery Gold Ghana Ltd. ("DGG" , has entered into an Extension of Option Agreement for the Edum Banso Concession (the "Extension Agreement" with the holder of the exploration concession license, Adom Mining. The Edum Banso Gold Project is strategically located in the southern portion of Ghana's prolific Ashanti gold belt.

Discovery Gold Highlights Strengths of West African Gold Exploration and Mining Sector
PR Newswire - Tue May 07, 6:45AM CDT
Discovery Gold Corporation (OTCQB-DCGD)(the "Company" , an emerging U.S. based mineral exploration company, is pleased to provide this latest management commentary concerning the current growth prospects and relative socio-political stability of the West African gold exploration and mining sectors, particularly in Ghana.

Discovery Gold Comments on Gold Price Drop and Strategic Geologic Location
PR Newswire - Tue Apr 23, 6:31AM CDT
On April 2nd, 2013, Discovery Gold Corporation (OTCQB-DCGD) (the "Company" commented in a press release about its geologic similarity (per its recent 43-101 report) to gold deposits being mined nearby in Ghana's prolific Ashanti Gold Belt; and the Company's President, Steve Flechner, noted his belief "that gold prices will remain strong." Ten days later, the price of gold plunged 4.7% on Friday and another 9.6% on Monday. This press release, therefore, is to briefly summarize a few of the reported apparent reasons for the historic price drop, and for continued confidence in the future for gold prices and for the potentially significantly underpriced stocks of strategically located gold exploration companies.

Discovery Gold Reviews Strategic Geologic Location and Gold Market
PR Newswire - Tue Apr 02, 9:30AM CDT
Last week, Discovery Gold Corporation (OTCQB: DCGD) (the "Company" posted the CNI 43-101 compliant Assessment Report for its Edum Banso Gold Project in Ghana (prepared by independent geologists from CME & Co who are highly experienced in Ghana); the Company also announced the trenching and initial drilling work program recommended in the Assessment Report to explore priority gold targets identified within Edum Banso's 8 km long geophysical gold anomaly, highlighted by historic gold in soil sampling and quartz outcrops reported by Newmont Gold and Xtra Gold in 2004 and 2008 when gold prices were below $1,000 per oz.

Discovery Gold Announces Work Program Recommended in 43-101 Assessment Report
PR Newswire - Tue Mar 26, 6:35AM CDT
Discovery Gold Corporation (OTCQB-DCGD) (the "Company" is pleased to announce that independent geologic consultants from CME & Co have completed and submitted their "Assessment" report including work recommendations for the Company's Edum Banso gold project located in the southeast of Ghana's historic and prolific gold producing Ashanti Gold Belt. CME has extensive mineral exploration and discovery experience in Ghana where Discovery Gold's President, Steven Flechner worked with them during the 1990s.

Discovery Gold Announces 43-101 Report Confirming Gold Bearing Quartz Vein Targets
PR Newswire - Tue Mar 19, 8:46AM CDT
Discovery Gold Corporation (OTCQB: DCGD) (the "Company" is pleased to announce that geologic consultants from CME & Co Enterprises Inc. of Vancouver, Canada ("CME" have received assay results from limited rock sampling and have substantially completed their preliminary "Assessment of the Edum Banso Property" for the Company. The Edum Banso Property is located in the south of Ghana's prolific Ashanti gold belt.

Discovery Gold Appoints Ghana Experienced Geologist and Exploration Consultant to Strategic Advisory Board
PR Newswire - Wed Mar 13, 9:32AM CDT
Discovery Gold Corporation (OTCQB: DCGD) ("Discovery Gold" or the "Company" is pleased to announce that the Company has appointed Mr. T. Greg Hawkins, M.Sc, P.Geo, to its Strategic Advisory Board. Currently, Mr. Hawkins (CME & Co Enterprises Inc.) is the senior geological consultant for the Company's Edum Banso Gold Project in Ghana.

Discovery Gold Consulting Geologists CME Complete Site Reconnaissance and Initial Rock Sampling
PR Newswire - Wed Jan 30, 10:21AM CST
Discovery Gold Corporation (OTCQB: DCGD) ("Discovery Gold" or the "Company" is pleased to announce that CME & Co Enterprises Inc. ("CME" , geological consultants for its Edum Banso Gold Project in Ghana, have completed initial site reconnaissance, conducted meetings with relevant surface rights holders, and collected additional samples of rock outcrops and subcrops from high priority targets on the property.

Discovery Gold Receives Ghana Ministry Consent and Signs Geological Consulting Agreement for Work on Edum Banso Gold Project
PR Newswire - Tue Jan 15, 8:15AM CST
Discovery Gold Corporation (OTCQB: DCGD) ("Discovery Gold" or the "Company" is pleased to announce (i) that the Company has received formal consent from the Ministry of Lands and Natural Resources of Ghana for its receipt of the assignment of the Option for the prospecting license for the Edum Banso gold project, and (ii) that the Company has executed a geological consulting agreement with CME & Co Enterprises Inc. of Vancouver for immediate undertaking of historic data compilation, site reconnaissance, and rock sampling work on the Edum Banso gold project.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 454

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 59

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 387

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 283

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 162

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 493

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Midea's R290 Tech: Real Green Cooling Revolution?

Updated Category News Views 66

A Fresh Breeze in Sustainable Cooling In the middle of Kigali’s innovation oasis, Midea RAC stood out at MOP38, the 38th Meeting of the Parties to the Montreal Protocol, flexing its sustainable tech muscles. We're talking about their R290 air conditioning technology—a natural refrigerant with zero ozone footprint and a global warming potential of a mere three. This is...

Continue Reading
Ampace Focuses on Battery Safety Standards at RE+ 2026

Updated Category News Views 77

Battery Safety Takes Center Stage No mystery here: the safety of our beloved lithium-ion batteries is crucial, especially as AI data centers sprout like weeds. At RE+ 2026, Ampace is putting its chips on the table by spotlighting this hot topic. Dr. Drew Feng, their Chief Safety Officer, is set to reveal the big guns: findings from the PU100 large-scale fire test. Mark...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 421

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 304

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading

Top 5 Most Recently Viewed Articles

Ventas to Showcase Investment Strategy at Real Estate Conference

Updated Category News Views 44

Ventas Engages Investors at Upcoming Conference Ventas, Inc. (NYSE: VTR) is gearing up to take part in significant investor meetings at the BofA Securities 2024 Global Real Estate Conference. This event presents a valuable chance for the company to connect with investors and share insights about its strategic direction and business model. Event Details and Participation...

Continue Reading
BioLineRx Explores Synergy in Ovarian Cancer Treatment

Updated Category News Views 151

New Hope on the Ovarian Cancer Front Every so often, something comes along and makes you stop and think—could this be the game-changer in the making? Well, what BioLineRx Ltd. (NASDAQ: BLRX) and Hemispherian AS just dropped at the ESMO 2026 feels a bit like that silver lining for folks fighting the uphill battle against homologous recombination (HR)-proficient ovarian...

Continue Reading
Analyst Ratings Show Confidence in Datadog and Others

Updated Category News Views 80

Recent Upgrades by Top Analysts Leading financial analysts from Wall Street have adjusted their outlooks on several prominent companies, reflecting a more optimistic market sentiment. Upgrades often signify increased confidence in a company's performance and present potential investment opportunities for savvy investors. Here, we delve into some of the standout upgrades...

Continue Reading
Unpacking the Increased Short Interest in Ventas (NYSE: VTR)

Updated Category News Views 77

Understanding Ventas's Short Interest Surge Ventas recently recorded an uptick in its short percent of float, which now stands at 25.59% since the last report. This notable development means that 9.80 million shares are currently sold short, translating to 3.19% of all regular shares available for trading. Given the trading volume, it would take traders approximately 3.33...

Continue Reading
Precigen's PAPZIMEOS: 7-Year Exclusivity & Long-Term Success

Updated Category News Views 54

Precigen's Game-Changer: PAPZIMEOS Secures Seven-Year Exclusivity Here's how you carve out a solid niche in the biotech world: deliver some killer results and snag yourself seven years in the driver’s seat. That's exactly what Precigen (NASDAQ: PGEN) has done with their PAPZIMEOS therapy, which got the stamp of approval from the FDA as the first exclusive treatment for...

Continue Reading